Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity - Papadopoulou - - eJHaem - Wiley Online Library
Αιματολογικός καρκίνος-Ομιλητές - ΕΛΛ.Ο.Κ.
THE IMPACT OF TREATMENT WITH BRENTUXIMAB VEDOTIN ON OVERALL.... EHA Library. Tsirigotis P. Jun 23 2017; 181567
ioannis Batsis - MD - General Hospital of Thessaloniki "George PAPANIKOLAOU" | LinkedIn
Positive impact of brentuximab vedotin on overall survival of patients with classical Hodgkin lymphoma who relapse or progress after autologous stem cell transplantation: A nationwide analysis - Tsirigotis - 2018 - Hematological
Αιματολογικός καρκίνος-Ομιλητές - ΕΛΛ.Ο.Κ.
Skewing of the T-cell receptor repertoire in patients receiving rituximab after allogeneic hematopoietic cell transplantation: what lies beneath?: Leukemia & Lymphoma: Vol 60, No 7
Β ΑΝΑΚΟΙΝΩΣΗ ΠΡΟΚΑΤΑΡΚΤΙΚΟ ΠΡΟΓΡΑΜΜΑ - PDF Free Download
Ioannis BATSIS | MD | BMT Unit
Αποτελέσματα Εκλογών - Θεσσαλονίκη: Οι σταυροί των υποψήφιων δημοτικών συμβούλων!
Frontiers | Risk Factors and Outcomes of Klebsiella pneumoniae Infection Before and After Allogeneic Hematopoietic Cell Transplantation | Medicine
Ioannis BATSIS | MD | BMT Unit
Easix Is Strongly Associated with Complement Activation and Overall Survival in Adult Allogeneic Hematopoietic Cell Transplantation Recipients - ScienceDirect
52% μείωσε τη θνητότητα από κορονοϊό ελληνική θεραπεία με Τ- λεμφοκύτταρα~Γιατί κράτος και ΕΟΦ ΚΩΦΕΎΟΥΝ; - Προϊόντα της Φύσης
Με άποψη: Πρώτα το εμβόλιο και ύστερα η θεραπεία
Allogeneic Hematopoietic Cell Transplantation with Myeloablative Conditioning Regimen of Reduced Toxicity Is Associated with Favorable Survival in Patients with Secondary Acute Myeloid Leukemia - ScienceDirect
Πρόγραμμα
PDF) Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity
Αιματολογικός καρκίνος-Ομιλητές - ΕΛΛ.Ο.Κ.
Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity - Papadopoulou - - eJHaem - Wiley Online Library
PDF) Allografted Recipients Immunized Against Hepatitis B Virus are at High Risk of Gradual Surface Antibody (HbsAb) Disappearance Post Transplant, Regardless of Adoptive Immunity Transfer